Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

News
Rumors

Hearing Cramer Buying Morgan Stanley

https://twitter.com/OracleNYSE/status/1456348958222077954

byBill Haddad

November 4, 2021

1 minute read

Cramer buying $MS

— Oracle (@OracleNYSE) November 4, 2021

HC Wainwright & Co. Maintains Buy on Leap Therapeutics, Lowers Price Target to $2.5

By Benzinga Newsdesk

Today, 8:11 AM

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Leap Therapeutics (NASDAQ:LPTX) with a Buy and lowers the price target from $4 to $2.5.

LPTX

RBC Capital Maintains Outperform on SOC Telemed, Lowers Price Target to $6

By Benzinga Newsdesk

Today, 8:11 AM

RBC Capital analyst Sean Dodge maintains SOC Telemed (NASDAQ:TLMD) with a Outperform and lowers the price target from $10 to $6.

TLMD

News

‘Mexican Senator To File Psychedelics Legalization Bill, With U.S. Congressman Backing International Reform Push’ – Marijuana Moment

By Happy Mohamed

Today, 8:11 AM

https://www.marijuanamoment.net/mexican-senator-to-file-psychedelics-legalization-bill-with-u-s-congressman-backing-international-reform-push/ A Mexican senator announced on Wednesday that she will be introducing a bill

CMPS

Edward Jones Upgrades Activision Blizzard to Buy

By Benzinga Newsdesk

Today, 8:11 AM

Edward Jones analyst Logan Purk upgrades Activision Blizzard (NASDAQ:ATVI) from Hold to Buy.

ATVI

Hearing Cramer Buying Morgan Stanley

Related Posts

HC Wainwright & Co. Maintains Buy on Leap Therapeutics, Lowers Price Target to $2.5

RBC Capital Maintains Outperform on SOC Telemed, Lowers Price Target to $6

‘Mexican Senator To File Psychedelics Legalization Bill, With U.S. Congressman Backing International Reform Push’ – Marijuana Moment

Edward Jones Upgrades Activision Blizzard to Buy